Bio Tech & Pharma Positive Phase 2a Fibromyalgia Study Demonstrates Pain Reduction in All Subjects, Enhancing Intellectual Property and Clinical Trial Approach.By Alexander LeeAugust 17, 20240 The Phase 1a trial of SZN-043 has shown evidence of target engagement and Wnt-pathway mediated pharmacodynamic effects in the liver.…
